steatotic liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >=6 years and <18 years, male or female; 2. Definite diagnosis of steatotic liver disease or steatohepatitis by liver pathology; 3. Weight change <5% in the last 3 months; 4. Signing of the informed consent form;
Exclusion criteria
Exclusion criteria: 1. Combined with other etiologies, e.g. hepatitis B, hepatitis C, alcoholic liver disease, etc. 2. Other etiologies of hepatic steatosis, e.g. Wilson's disease, medications, total parenteral nutrition, etc. 3. Other serious diseases, e.g. cardiac, pulmonary, renal, hematological, and malignant neoplastic diseases. 4. After metabolic surgery. 5. Inability to perform transient elastography, e.g., combined ascites, right upper abdominal scarring, unhealed right upper abdominal wound, intracavitary implanted devices, etc. 6. Any other condition that, in the judgment of the investigator, makes participation in this study inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver stiffness measurement value;Fat ultrasound attenuation parameter; | — |
Secondary
| Measure | Time frame |
|---|---|
| Consistency;Influencing factors of LSM and UAP;The clinical value of different stages of fibrosis; | — |
Countries
China
Contacts
Beijing You'an Hospital, Capital Medical University